Literature DB >> 10681522

Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.

R Zhao1, Z J Zhao.   

Abstract

Tyrosine phosphorylation of membrane proteins plays a crucial role in cell signaling by recruiting Src homology 2 (SH2) domain-containing signaling molecules. Recently, we have isolated a transmembrane protein designated PZR that specifically binds tyrosine phosphatase SHP-2, which has two SH2 domains (Zhao, Z. J., and Zhao, R. (1998) J. Biol. Chem. 273, 29367-29372). PZR belongs to the immunoglobulin superfamily. Its intracellular segment contains four putative sites of tyrosine phosphorylation. By site-specific mutagenesis, we found that the tyrosine 241 and 263 embedded in the consensus immunoreceptor tyrosine-based inhibitory motifs VIYAQL and VVYADI, respectively, accounted for the entire tyrosine phosphorylation of PZR. The interaction between PZR and SHP-2 requires involvement of both tyrosyl residues of the former and both SH2 domains of the latter, since its was disrupted by mutating a single tyrosyl residue or an SH2 domain. Overexpression of catalytically inactive but not active forms of SHP-2 bearing intact SH2 domains in cells caused hyperphosphorylation of PZR. In vitro, tyrosine-phosphorylated PZR was efficiently dephosphorylated by the full-length form of SHP-2 but not by its SH2 domain-truncated form. Together, the data indicate that PZR serves not only as a specific anchor protein of SHP-2 on the plasma membrane but also as a physiological substrate of the enzyme. The coexisting binding and dephosphorylation of PZR by SHP-2 may function to terminate signal transduction initiated by PZR and SHP-2 and to set a threshold for the signal transduction to be initiated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681522     DOI: 10.1074/jbc.275.8.5453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.

Authors:  Geraldine Ferjoux; Frederic Lopez; Jean-Pierre Esteve; Audrey Ferrand; Eric Vivier; Frederic Vely; Nathalie Saint-Laurent; Lucien Pradayrol; Louis Buscail; Christiane Susini
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

Review 3.  Mining the function of protein tyrosine phosphatases in health and disease.

Authors:  Hojin Lee; Jae-Sung Yi; Ahmed Lawan; Kisuk Min; Anton M Bennett
Journal:  Semin Cell Dev Biol       Date:  2014-09-26       Impact factor: 7.727

4.  Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration.

Authors:  Andrew C W Zannettino; Maria Roubelakis; Katie J Welldon; Denise E Jackson; Paul J Simmons; Linda J Bendall; Anthony Henniker; Kate L Harrison; Silvana Niutta; Kenneth F Bradstock; Suzanne M Watt
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

5.  PZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.

Authors:  Jeroen Paardekooper Overman; Jae-Sung Yi; Monica Bonetti; Matthew Soulsby; Christian Preisinger; Matthew P Stokes; Li Hui; Jeffrey C Silva; John Overvoorde; Piero Giansanti; Albert J R Heck; Maria I Kontaridis; Jeroen den Hertog; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2014-05-27       Impact factor: 4.272

6.  Phosphorylation and localization of protein-zero related (PZR) in cultured endothelial cells.

Authors:  Ken-ichi Kusano; Tamlyn N Thomas; Keigi Fujiwara
Journal:  Endothelium       Date:  2008 May-Jun

7.  Low-dose dasatinib rescues cardiac function in Noonan syndrome.

Authors:  Jae-Sung Yi; Yan Huang; Andrea T Kwaczala; Ivana Y Kuo; Barbara E Ehrlich; Stuart G Campbell; Frank J Giordano; Anton M Bennett
Journal:  JCI Insight       Date:  2016-12-08

8.  Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).

Authors:  Helen Wheadon; Christine Edmead; Melanie J Welham
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

9.  Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.

Authors:  Seda Eminaga; Anton M Bennett
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

10.  Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.

Authors:  Jae-Sung Yi; Sravan Perla; Liz Enyenihi; Anton M Bennett
Journal:  JCI Insight       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.